Boxer Capital’s Achieve Life Sciences ACHV Stock Holding History

Boxer Capital’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-40	Closed	-$60K	–	24
2016 Q1	$60K	Buy	+40	New	+$65.2K	0.06%	22

Other funds holding ACHV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boxer Capital's ACHV Position: Q2 2016 in Review

Boxer Capital sold out of Achieve Life Sciences (ACHV) in Q2 2016, closing a stake of 40 shares — an estimated $60K sold.

Boxer Capital first reported a position in ACHV in Q1 2016 and held it in 1 quarter. The position peaked at $60K in Q1 2016. 34 funds tracked by Wall St. Rank hold ACHV as of Q2 2016.

Boxer Capital reported no remaining Achieve Life Sciences position as of Q2 2016 after selling out during the quarter.
Boxer Capital sold 40 Achieve Life Sciences shares in Q2 2016, an estimated $60K.
Boxer Capital first reported a position in Achieve Life Sciences in Q1 2016 and held it in 1 quarter.
Boxer Capital's Achieve Life Sciences position peaked at $60K in Q1 2016.
34 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2016.

Based on Boxer Capital's 13F filing for Q2 2016, filed 15 Aug 2016.